Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
How do we manage and treat a patient with multiple sclerosis at risk of tuberculosis?
The association between fatigue and apathy in patients with either Parkinson's disease or multiple sclerosis.
CCL27: Novel Cytokine with Potential Role in Pathogenesis of Multiple Sclerosis.
Is the Relationship between Cortical and White Matter Pathologic Changes in Multiple Sclerosis Spatially Specific? A Multimodal 7-T and 3-T MR Imaging Study with Surface and Tract-based Analysis.
Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression.
Translating CESD-20 and PHQ-9 Scores to PROMIS Depression.
Relationship Between Botulinum Toxin, Spasticity, and Pain: a Survey of Patient Perception.
Ultrasonographic nerve enlargement of the median and ulnar nerves and the cervical nerve roots in patients with demyelinating Charcot-Marie-Tooth disease: distinction from patients with chronic inflammatory demyelinating polyneuropathy.
Diabetes insipidus as a rare cause of acute cognitive impairment in multiple sclerosis.
A possible case of acute disseminated encephalomyelitis after Japanese encephalitis.
Collateral benefit: the comeback of MOG antibodies as a biomarker in neurological practice.
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation.
Sex-Based Differences in Multiple Sclerosis (Part I): Biology of Disease Incidence.
Sex-Based Differences in Multiple Sclerosis (MS): Part II: Rising Incidence of Multiple Sclerosis in Women and the Vulnerability of Men to Progression of this Disease.
Multiple sclerosis: Biomarkers predict conversion from clinically isolated syndrome to multiple sclerosis.
Detecting deoxyhemoglobin in spinal cord vasculature of the experimental autoimmune encephalomyelitis mouse model of multiple sclerosis using susceptibility MRI and hyperoxygenation.
Regulatory Effect of 25-hydroxyvitamin D3 on Nitric Oxide Production in Activated Microglia.
Long-term safety of azathioprine therapy in multiple sclerosis.
Extensive acute axonal damage in pediatric multiple sclerosis lesions.
Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis.
Restoring nervous system structure and function using tissue engineered living scaffolds.
Microglial P2 Purinergic Receptor and Immunomodulatory Gene Transcripts Vary By Region, Sex, and Age in the Healthy Mouse CNS.
Cost-effectiveness of natalizumab in multiple sclerosis: an updated systematic review.
[Multimodal complex treatment in advanced multiple sclerosis.]
Bone marrow derived elements and resident microglia in brain inflammation.
Pages
« first
‹ previous
…
528
529
530
531
532
533
534
535
536
…
next ›
last »